Corvus Pharmaceuticals Inc.
CRVS | NASDAQ
$12.94
+$0.52 (+4.19%)
Sep 22, 2026, 10:39 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 55K | 55K | 26K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -55K | -55K | -26K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -56.96M | -47.93M | -42.97M | -38.86M | -35.54M | -31.22M | -27.55M | -25.09M | -23.4M | -23.09M | -23.41M | -23.42M | -30.34M | -31.73M | -32.57M | -33.71M | -30.28M | -34.56M | -38.63M | -41.7M | -42.5M | -41.97M |
Interest Income | -1.16M | -525K | n/a | 2.41M | 2.24M | 2.03M | 1.82M | 1.7M | 1.56M | 1.52M | 1.58M | 1.52M | 1.32M | 1.02M | 654K | 336K | 111K | 12K | 4K | 5K | 54K | 209K |
Pretax Income | -53.42M | -44.17M | -15.28M | -15.08M | -45.14M | -41.4M | -62.29M | -56.83M | -22.62M | -24.86M | -27.03M | -30.19M | -39.02M | -40.88M | -41.31M | -40.73M | -36.57M | -39.96M | -43.24M | -6.66M | -5.78M | -4.64M |
Net Income | -54.13M | -44.17M | -15.28M | -15.08M | -45.14M | -41.4M | -62.29M | -56.83M | -22.62M | -24.86M | -27.03M | -30.19M | -39.02M | -40.88M | -41.31M | -40.73M | -36.57M | -39.96M | -43.24M | -6.66M | -5.78M | -4.64M |
Selling & General & Admin | 11.43M | 10.49M | 9.25M | 9.11M | 9.02M | 8.45M | 8.16M | 7.68M | 7.25M | 7.08M | 6.88M | 6.82M | 7.33M | 7.76M | 8.1M | 8.53M | 8.48M | 8.58M | 9.52M | 10.18M | 11.35M | 12.08M |
Research & Development | 45.53M | 37.44M | 33.72M | 29.75M | 26.52M | 22.76M | 19.39M | 17.41M | 16.15M | 16.01M | 16.53M | 16.61M | 23.01M | 23.96M | 24.47M | 25.18M | 21.8M | 25.99M | 29.12M | 31.52M | 31.15M | 29.9M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 56.94M | 47.9M | 42.95M | 38.86M | 35.54M | 31.22M | 27.55M | 25.09M | 23.4M | 23.09M | 23.41M | 23.42M | 30.34M | 31.73M | 32.57M | 33.71M | 30.28M | 34.56M | 38.63M | 41.7M | 42.5M | 41.97M |
Interest Expense | 1.78M | 1.78M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8K | 19K | 19K | 19K | 11K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 56.96M | 47.93M | 42.97M | 38.86M | 35.54M | 31.22M | 27.55M | 25.09M | 23.4M | 23.09M | 23.41M | 23.42M | 30.34M | 31.73M | 32.57M | 33.71M | 30.28M | 34.56M | 38.63M | 41.7M | 42.5M | 41.97M |
Income Tax Expense | 709K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 92.37M | 90M | 78.96M | 82.84M | 77.77M | 72.13M | 68.35M | 66.7M | 59.71M | 49.04M | 49.04M | 48.97M | 47.5M | 46.56M | 46.55M | 46.55M | 46.55M | 46.55M | 46.55M | 43.95M | 42.25M | 34.52M |
Shares Outstanding (Diluted) | 92.37M | 90M | 79.74M | 82.84M | 77.77M | 75.15M | 68.35M | 66.7M | 59.71M | 49.04M | 49.04M | 48.97M | 47.5M | 46.56M | 46.55M | 46.55M | 46.55M | 46.55M | 46.55M | 43.95M | 42.25M | 34.52M |
EPS (Basic) | -0.64 | -0.55 | -0.19 | -0.19 | -0.67 | -0.64 | -0.97 | -0.93 | -0.45 | -0.52 | -0.57 | -0.64 | -0.84 | -0.88 | -0.89 | -0.88 | -0.80 | -0.90 | -1.06 | 0.06 | -0.03 | -0.11 |
EPS (Diluted) | -0.64 | -0.55 | -0.53 | -0.53 | -1.01 | -0.98 | -0.97 | -0.93 | -0.45 | -0.52 | -0.57 | -0.64 | -0.84 | -0.88 | -0.89 | -0.88 | -0.80 | -0.90 | -1.06 | 0.06 | -0.03 | -0.11 |
EBITDA | -51.49M | -42.27M | -15.18M | -14.98M | -45.04M | -41.32M | -62.21M | -56.74M | -22.51M | -24.74M | -26.88M | -29.98M | -38.74M | -40.55M | -40.94M | -40.35M | -36.17M | -39.53M | -42.67M | -43.27M | -42.41M | -41.39M |
EBIT | -51.64M | -42.38M | -15.28M | -15.08M | -45.14M | -41.4M | -62.29M | -56.83M | -22.62M | -24.86M | -27.03M | -30.19M | -39.02M | -40.88M | -41.31M | -40.72M | -36.55M | -39.94M | -43.13M | -43.78M | -42.96M | -41.97M |
Depreciation & Amortization | 146K | 112K | 105K | 99K | 92K | 84K | 85K | 93K | 102K | 117K | 151K | 217K | 281K | 337K | 367K | 366K | 380K | 410K | 460K | 509K | 548K | 585K |
Add to Watchlist
Select watchlists to add or remove CRVS